Von dem Buch Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary haben wir 3 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Board on Health Sciences Policy: Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary (ISBN: 9780309253185) 2011, National Academies Press, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
100%: Board on Health Sciences Policy: Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary (ISBN: 9780309253161) 2011, National Academies Press, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
97%: Development, and Translation Forum on Drug Discovery, Board on Health Sciences Policy, Institute of Medicine, Neil Weisfeld (Editor), Rebecca A. English (Editor), Anne B. Claiborne (Editor): Envisioning Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (ISBN: 9780309253154) 2012, National Academies Press, in Englisch, Taschenbuch.Nur diese Ausgabe anzeigen…
Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary
7 Angebote vergleichen
Bester Preis: € 52,54 (vom 06.09.2019)1
Envisioning a Transformed Clinical Trials Enterprise in the United States, Establishing an Agenda for 2020: Workshop Summary (2012)
EN PB NWISBN: 9780309253154 bzw. 0309253152, in Englisch, National Academies Press, Taschenbuch, neu.
Lieferung aus: Niederlande, Vermoedelijk 4-6 weken.
bol.com.
There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, ... There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop.Soort: Met illustraties;Taal: Engels;Afmetingen: 0x229x152 mm;Verschijningsdatum: september 2012;ISBN10: 0309253152;ISBN13: 9780309253154; Engelstalig | Paperback | 2012.
bol.com.
There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, ... There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop.Soort: Met illustraties;Taal: Engels;Afmetingen: 0x229x152 mm;Verschijningsdatum: september 2012;ISBN10: 0309253152;ISBN13: 9780309253154; Engelstalig | Paperback | 2012.
2
Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary (2011)
~EN NW EB DLISBN: 9780309253185 bzw. 0309253187, vermutlich in Englisch, National Academies Press, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Free shipping.
Envisioning a Transformed Clinical Trials Enterprise in the United States: There is growing recognition that the United States` clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop. Englisch, Ebook.
Envisioning a Transformed Clinical Trials Enterprise in the United States: There is growing recognition that the United States` clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop. Englisch, Ebook.
3
Envisioning a Transformed Clinical Trials Enterprise in the United States - Establishing an Agenda for 2020: Workshop Summary (2011)
~EN NW EB DLISBN: 9780309253161 bzw. 0309253160, vermutlich in Englisch, National Academies Press, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Free shipping.
Envisioning a Transformed Clinical Trials Enterprise in the United States: There is growing recognition that the United States` clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop. Englisch, Ebook.
Envisioning a Transformed Clinical Trials Enterprise in the United States: There is growing recognition that the United States` clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions.With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop. Englisch, Ebook.
4
Symbolbild
Envisioning Transformed Clinical Trials Enterprise in the United States; Establishing an Agenda for 2020; Workshop Summary (2012)
EN PB NWISBN: 9780309253154 bzw. 0309253152, in Englisch, National Academies Press, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Powell's Books, OR, Portland, [RE:5].
S Softcover.
Von Händler/Antiquariat, Powell's Books, OR, Portland, [RE:5].
S Softcover.
5
Symbolbild
Envisioning Transformed Clinical Trials Enterprise in the United States; Establishing an Agenda for 2020; Workshop Summary (2012)
EN PB NWISBN: 9780309253154 bzw. 0309253152, in Englisch, National Academies Press, Taschenbuch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Gulls Nest Books, OR, Portland, [RE:5].
Softcover.
Von Händler/Antiquariat, Gulls Nest Books, OR, Portland, [RE:5].
Softcover.
6
Symbolbild
Forum On Drug Discovery, Development, And Translation; Board On Health Sciences Policy; Institute Of Medicine; Neil Weisfeld...
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012)
EN PB USISBN: 9780309253154 bzw. 0309253152, in Englisch, National Academies Press, Taschenbuch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, Neutral Balloon Books, PA, Narberth, [RE:4].
Paperback.
Von Händler/Antiquariat, Neutral Balloon Books, PA, Narberth, [RE:4].
Paperback.
7
Symbolbild
Development, And Translation Forum On Drug Discovery, Board On Health Sciences Policy, Institute Of Medicine, Neil Weisfeld...
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012)
EN PB USISBN: 9780309253154 bzw. 0309253152, in Englisch, National Academies Press, Taschenbuch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Verandgebiet: DOM.
Von Händler/Antiquariat, ExtremelyReliable, TX, Richmond, [RE:4].
Paperback.
Von Händler/Antiquariat, ExtremelyReliable, TX, Richmond, [RE:4].
Paperback.
Lade…